AGTC Receives Grant from Food and Drug Administration for Clinical Study of Genetic Retinal Disease

AGTC has received a $1 million grant from the FDA to run a clinical trial for its treatment of Leber's disease, which causes blindness at an early age.... [more]

View complete Miami Herald article